InMode has a strong competitive position in the rapidly growing global aesthetic market with its innovative products and technology. The company has achieved impressive financial performance with ...
InMode's Q4 revenue dropped YOY; management optimistic about new platforms despite industry challenges. High dependence on U.S. revenue from minimally invasive procedures; facing increasing ...
InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that Moshe Mizrahy, ...
InMode (NASDAQ:INMD) is a promising aesthetic medical product player. Its proprietary radio frequency platform is the focal point of its innovative product offering. However, the company’s financial ...
InMode Ltd, a leading global provider of innovative medical technologies, announced that the US Patent and Trademark Office (USPTO) has granted to InMode Patent No. 10.799.285 covering its Morphues8 ...
YOKNEAM, Israel, Jan. 8, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that it expects to release its financial results ...
On Wednesday, 11 March 2026, InMode Ltd (NASDAQ:INMD) presented its strategic vision at the Barclays 28th Annual Global Healthcare Conference. The company, navigating a challenging market environment, ...
YOKNEAM, Israel, Feb. 3, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that Yair Malca, Chief Financial Officer will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results